Page 6 - Gates-AnnualReport-2017

WHO WE ARE
Established in 2006 with a generous gift in Charles Gates’ memory, the Gates Center for Regenerative Medicine is a world-class, multi-institutional center headquartered on the University of Colorado Anschutz Medical Campus, researching transformative human therapies using stem cells and other tools while shepherding clinical trials to bring them to patients as quickly as possible.
We are:
• Inspired by Charlie Gates’ vision of the future of regenerative medicine and guided by four strategic drivers that distinguish our approach:
° Frontier Spirit: Do business in an entrepreneurial
way, balancing risks, opportunities and resources
while minimizing barriers to success.
° Talent: Focus on the acquisition, development and
retention of accomplished, passionate, innovative
change agents, both clinicians and basic scientists.
° Collaboration: Serve as an indispensable resource, supporting, coordinating and optimizing outcomes for all of our partners and customers – “No one does
their best work alone.” – Charles Gates
° Patient Outcomes: Accelerate discoveries from the lab through clinical trials leading to effective
therapies and cures.
• Led by Professor Dennis Roop, Ph.D., who was recruited from the Baylor College of Medicine in January 2007, to establish a critical mass of faculty, clinicians, students, research staff and administrators to execute the center’s mission.
• Supported by an extraordinary Gates Center Advisory Board (see photo on opposite page)
• Dedicated to bringing together outstanding medical
researchers and clinicians and providing the following to accelerate discoveries into clinical practice as quickly as possible:
° Grant and philanthropic funding
° Four state-of-the-art core scientific facilities
° The Gates Biomanufacturing Facility, in which future cellular therapies and protein-based biologics are being manufactured for human trials under the highest FDA standards—one of six combined cell therapy and protein manufacturing facilities in the United States and the only one of its kind within an
800-mile radius
° Commercialization support ° Education and outreach
• Comprised of 97 multi-institutional members from the University of Colorado Anschutz Medical Campus, CU Boulder, CU Denver, Colorado State University, Colorado School of Mines, National Jewish Health and private industry, investigating regenerative therapies and stem cell treatments in the areas of bioengineering, cardiology, dermatology, diabetes, immunology, neurology, oncology, ophthalmology, and orthopedics, among others specified on our list of members on page 9.
• Focused on adult stem cells, which can be reprogrammed into embryonic-like stem cells, referred to as induced Pluripotent Stem Cells (iPSCs), and then differentiated into virtually any cell type in the body. The long-term goal is to return genetically corrected iPSC-derived adult stem cells to the patient from which they were derived. In this way, the Gates Center’s clinical pathway is leading toward a new paradigm of personalized medicine in which an individual’s own cells can be used to cure a number of diseases and conditions.
6 Gates Center for Regenerative Medicine